Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$914.37 8.99 (0.99%) as of 4:30 Mon 7/1


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 874.67(B)
Last Volume: 2,545,641 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 53 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2015-02-01 4 D $72.00 $177,624 D/D (2,467) 41,807     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 5,246 44,274     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2015-02-01 4 D $72.00 $284,184 D/D (3,947) 67,610     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 8,394 71,557     -
   Lundberg Jan M EVP,Science&Tech and Pres. LRL   •       –      –    2015-02-01 4 D $72.00 $712,800 D/D (9,900) 210,216     -
   Lundberg Jan M EVP,Science&Tech and Pres. LRL   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 20,985 220,116     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-02-01 4 D $72.00 $1,776,096 D/D (24,668) 662,416     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-02-01 4 OE $0.00 $0 D/D 52,462 687,084     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-02-01 4 D $72.00 $885,168 D/D (12,294) 70,445     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 26,581 82,739     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-02-01 4 D $72.00 $426,312 D/D (5,921) 87,487     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 12,591 93,408     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2015-02-01 4 D $72.00 $419,328 D/D (5,824) 113,856     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 12,591 119,680     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-02-01 4 D $72.00 $427,680 D/D (5,940) 68,054     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 12,591 73,994     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2015-02-01 4 D $72.00 $475,776 D/D (6,608) 111,782     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 13,990 118,390     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2015-02-01 4 D $72.00 $298,584 D/D (4,147) 62,745     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2015-02-01 4 OE $0.00 $0 D/D 9,094 66,892     -
   Alvarez Ralph Director   –       •      –    2015-01-30 4 A $72.03 $9,940 D/D 138 26,712     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2015-01-28 4 A $70.97 $529,862 D/D 7,466 38,518     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2015-01-28 4 A $70.97 $208,865 D/D 2,943 6,587     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-01-28 4 A $70.97 $3,985,533 D/D 56,158 56,158     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2015-01-28 4 A $70.97 $818,426 D/D 11,532 52,692     -
  1436 Records found
  Previous  50  51  52  53  54  55  56  57  58   
  Page 53 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us